best price lightwave tent cheap office 2013 purchase project standard 2007 buy adobe audition cc 2014 software cheap windows 7 ultimate retail buy office outlook 2007 canada purchase microsoft office 2003 product key price of windows server 2008 enterprise edition best price windows xp home edition windows home server 2011 cheap buy server 2003 r2 enterprise cheapest office 2013 price adobe photoshop cs5 extended best buy cost of solidworks 2010 premium buy cs5 mac price
cheapest nero 9 reloaded price of adobe photoshop cs2 dreamweaver uk price buy photoshop elements 8 cheap spyware doctor with antivirus purchase adobe photoshop cs3 extended price of adobe acrobat professional 9 adobe premiere pro cc 2014 mac prices purchase windows xp home download buy quarkxpress 8 upgrade buy encarta 2010 buy mac os x 10.8 mountain lion discount corel draw x4 buy ms office 2003 licenses buy autocad 2005

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

Mon, Jun 20, 2011

Oral Cancer News

Source: The Lancet



Australia introduced a human papillomavirus (HPV) vaccination programme with the quadrivalent HPV vaccine for all women aged 12—26 years between 2007 and 2009. We analysed trends in cervical abnormalities in women in Victoria, Australia, before and after introduction of the vaccination program.


With data from the Victorian Cervical Cytology Registry between 2003 and 2009, we compared the incidence of histopathologically defined high-grade cervical abnormalities (HGAs, lesions coded as cervical intraepithelial neoplasia of grade 2 or worse or adenocarcinoma in situ; primary outcome) and low-grade cytological abnormalities (LGAs) in five age groups before (Jan 1, 2003, to March 31, 2007) and after (April 1, 2007, to Dec 31, 2009) the vaccination programme began. Binary comparisons between the two periods were done with Fisher’s exact test. Poisson piecewise regression analysis was used to compare incident rate trends.


After the introduction of the vaccination programme, we recorded a decrease in the incidence of HGAs by 0·38% (95% CI 0·61—0·16) in girls younger than 18 years. This decrease was progressive and significantly different to the linear trend in incidence before introduction of the vaccination (incident rate ratio 1·14, 1·00—1·30, p=0·05). No similar temporal decline was recorded for LGAs or in older age groups.


This is the first report of a decrease in incidence of HGAs within 3 years after the implementation of a population-wide HPV vaccination programme. Linkage between vaccination and screening registers is needed to confirm that this ecological observation is attributable to vaccination and to monitor participation in screening among vaccinated women.



Print Friendly
Be Sociable, Share!
, , , ,

Leave a Reply

You must be logged in to post a comment.